Senior insider sale
CEO at EAGLE PHARMACEUTICALS, INC. — senior position signals high conviction
$150.0K
9.51K shares
What this filing means
TARRIFF SCOTT plans to sell 9.51K shares of EAGLE PHARMACEUTICALS, INC. valued at approximately $150.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/2/2023ACC: 0001972649-23-000002
DirectorOfficer· CEO
Since Jun 2018
9.51K
Shares to sell
$150.0K
Approx. market value
9.51K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Executive Compensation
Cash
1/23/2022
2.95KExecutive Compensation
Cash
1/23/2019
6.57KTotal acquired9.51K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/23/2022 | Executive Compensation Cash | 2.95K | — |
1/23/2019 | Executive Compensation Cash | 6.57K | — |
| Total | 9.51K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
9.51K
Market value
$150.0K
10/2/2023
Total
Units
9.51K
Value
$150.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
10/2/2023 | 9.51K | $150.0K | NASDAQ | Planned |
| Total | 9.51K | $150.0K | ||